A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Image supplied by WEHI. Calmodulin binds to PSKH1 (in grey) to 'switch on' PSKH1 activity. Reticulocalbin binds to PSKH1 to 'switch off' PSKH1 ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

A psychologist says a bedroom routine many of us are uncomfortable discussing could help you sleep, reduce the risk of one cancer by 31per cent and boost your mood - as well as helping to cure a ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Glenn Bauman discussing a prospective provincial registry of PSMA PET/CT for recurrent prostate cancer. While most ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® ...